Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 1954970)

Published in Gut on February 01, 2007

Authors

Ricard Farré1, Rita De Vos, Karel Geboes, Kristine Verbecke, Pieter Vanden Berghe, Inge Depoortere, Kathleen Blondeau, Jan Tack, Daniel Sifrim

Author Affiliations

1: Center for Gastroenterological Research, Catholic University Leuven, Belgium.

Articles citing this

Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol (2012) 2.68

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28

Esophageal sensation and esophageal hypersensitivity - overview from bench to bedside. J Neurogastroenterol Motil (2010) 1.15

The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol (2010) 1.08

Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease. J Neurogastroenterol Motil (2015) 0.96

Barrett esophagus: an update. Nat Rev Gastroenterol Hepatol (2010) 0.92

Relevance of ultrastructural alterations of intercellular junction morphology in inflamed human esophagus. J Neurogastroenterol Motil (2013) 0.90

Intraluminal acid activates esophageal nodose C fibers after mast cell activation. Am J Physiol Gastrointest Liver Physiol (2013) 0.88

Gastrointestinal mucosal barrier function and diseases. J Gastroenterol (2016) 0.85

Role of corticotrophin-releasing factor in the stress-induced dilation of esophageal intercellular spaces. J Korean Med Sci (2011) 0.84

Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract (2013) 0.83

Is intercellular space different among layers in normal esophageal mucosa? An electron microscopic study. Dig Dis Sci (2011) 0.83

Patients with refractory reflux symptoms: What do they have and how should they be managed? Neurogastroenterol Motil (2015) 0.82

Role of tight junction proteins in gastroesophageal reflux disease. BMC Gastroenterol (2012) 0.82

Lateral cell membranes and shunt resistance in rabbit esophageal epithelium. Dig Dis Sci (2010) 0.81

Intercellular space volume is mainly increased in the basal layer of esophageal squamous epithelium in patients with GERD. Dig Dis Sci (2010) 0.80

Stress-related changes in oesophageal permeability: filling the gaps of GORD? Gut (2007) 0.79

Factors influencing intercellular spaces in the rat esophageal epithelium. World J Gastroenterol (2010) 0.79

[Neurobiological subtypes of geriatric depression. Their importance for diagnosis and treatment]. Z Gerontol Geriatr (2013) 0.78

Dilated intercellular spaces and chronic cough as an extra-oesophageal manifestation of gastrooesophageal reflux disease. Pulm Pharmacol Ther (2010) 0.78

Alterations in the non-neuronal acetylcholine synthesis and release machinery in esophageal epithelium. Life Sci (2012) 0.76

Estrogen Enhances Esophageal Barrier Function by Potentiating Occludin Expression. Dig Dis Sci (2015) 0.76

A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model. Am J Physiol Gastrointest Liver Physiol (2016) 0.75

Biomarkers of Reflux Disease. Clin Gastroenterol Hepatol (2015) 0.75

Impaired Esophageal Mucosal Integrity May Play a Causative Role in Patients With Nongastroesophageal Reflux Disease-Related Noncardiac Chest Pain. Medicine (Baltimore) (2015) 0.75

Reflux Hypersensitivity: A New Functional Esophageal Disorder. J Neurogastroenterol Motil (2017) 0.75

Articles cited by this

Intestinal permeability: an overview. Gastroenterology (1995) 5.36

Basic and clinical aspects of visceral hyperalgesia. Gastroenterology (1994) 4.39

Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet (2000) 2.21

Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol (2005) 2.06

Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology (2002) 2.02

The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology (2005) 2.00

Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium. Gastroenterology (1996) 1.81

Nonerosive reflux disease--current concepts and dilemmas. Am J Gastroenterol (2001) 1.75

Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol (2004) 1.62

Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol (2005) 1.60

Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil (2006) 1.51

Functional heartburn: the stimulus, the pain, and the brain. Gut (2002) 1.51

Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil (1997) 1.50

Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol (2001) 1.42

Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology (2000) 1.35

The effect of life stress on symptoms of heartburn. Psychosom Med (2004) 1.28

Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology (1988) 1.26

Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol (2005) 1.26

Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol (2003) 1.25

Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut (2000) 1.20

Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun (1999) 1.18

Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol (2001) 1.16

Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol (2000) 1.13

Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci (2002) 1.11

Non-cardiac chest pain: an update. Neurogastroenterol Motil (2006) 1.04

Post-stress recovery of pituitary-adrenal hormones and glucose, but not the response during exposure to the stressor, is a marker of stress intensity in highly stressful situations. Brain Res (2002) 1.04

Cold-restraint stress increases rat fecal pellet output and colonic transit. Am J Physiol (1990) 1.03

Role of mast cell-derived mediators in acid-induced shortening of the esophagus. Am J Physiol (1998) 0.99

Dilated intercellular spaces as markers of reflux disease: histology, semiquantitative score and morphometry upon light microscopy. Digestion (2001) 0.97

The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol (1993) 0.95

Oesophageal epithelial ultrastructure after incubation with gastrointestinal fluids and their components. J Pathol (1981) 0.95

Effect of stress on the paracellular barrier in the rat ileum. Gut (2002) 0.94

Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol (2005) 0.94

Vegetative innervation of the esophagus. III. Intraepithelial endings. Acta Anat (Basel) (1975) 0.94

Repeated, but not acute, stress suppresses inflammatory plasma extravasation. Proc Natl Acad Sci U S A (1999) 0.93

The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat. Am J Med Sci (1991) 0.92

Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease. Dig Dis Sci (2005) 0.90

Electron microscopic changes in human oesophageal epithelium in oesophagitis. J Pathol (1979) 0.90

Ultrastructural investigation of epithelial damage in asthmatic and non-asthmatic nasal polyps. Respir Med (2006) 0.89

Barriers to paracellular permeability in rabbit esophageal epithelium. Gastroenterology (1992) 0.87

Inhibition of substance P activity prevents stress-induced bladder damage. Regul Pept (2005) 0.86

The effects of cold-restraint stress on urinary bladder wall compared with interstitial cystitis morphology. Urol Res (1999) 0.86

Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium. Pharm Res (1994) 0.85

The role of acid in upper gastrointestinal haemorrhage due to ulcer and stress-related mucosal damage. Aliment Pharmacol Ther (1995) 0.84

Cold restraint stress-induced gastric mucosal dysfunction. Role of nitric oxide. Dig Dis Sci (1996) 0.82

Mast cell distribution in rats. Arzneimittelforschung (1994) 0.78

The effect of stress on the gastric mucosal barrier in rats. Proc Soc Exp Biol Med (1977) 0.78

Articles by these authors

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16

Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med (2005) 6.33

Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell (2007) 5.91

The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology (2005) 3.72

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology (2006) 3.68

Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology (2012) 3.35

The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol (2004) 3.25

Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol (2004) 3.04

Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol (2013) 2.98

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol (2002) 2.94

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med (2011) 2.60

The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology (2002) 2.58

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis (2012) 2.55

The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol (2013) 2.41

Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology (2008) 2.40

Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut (2013) 2.26

The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21

Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol (2009) 2.10

Pro: Impedance testing is useful in the management of GERD. Am J Gastroenterol (2009) 2.09

Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med (2014) 2.05

Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology (2012) 2.03

Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol (2004) 2.01

Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol (2006) 2.00

Glial cells in the mouse enteric nervous system can undergo neurogenesis in response to injury. J Clin Invest (2011) 1.99

The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut (2010) 1.89

Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology (2010) 1.89

Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88

Reproducibility and agreement of pharyngeal automated impedance manometry with videofluoroscopy. Clin Gastroenterol Hepatol (2011) 1.84

Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics (2006) 1.82

A novel method for the nonradiological assessment of ineffective swallowing. Am J Gastroenterol (2011) 1.81

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet (2005) 1.78

Atonal homolog 1 is a tumor suppressor gene. PLoS Biol (2009) 1.76

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2005) 1.73

Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci (2004) 1.73

Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc Natl Acad Sci U S A (2011) 1.69

In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut (2012) 1.64

Nerve activity recordings in routine human intestinal biopsies. Gut (2012) 1.59

Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology (2005) 1.58

Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol (2005) 1.56

Defining thresholds of antibody levels improves diagnosis of celiac disease. Clin Gastroenterol Hepatol (2012) 1.55

Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology (2002) 1.55

Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw (2006) 1.52

High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology (2008) 1.51

Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol (2013) 1.50

Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol (2004) 1.50

Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology (2007) 1.48

Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci U S A (2005) 1.48

Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol (2009) 1.48

Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology (2005) 1.46

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol (2005) 1.44

Identification of telocytes in the upper lamina propria of the human urinary tract. J Cell Mol Med (2012) 1.43

The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability. Liver Transpl (2008) 1.41

[Comparative prospective study of two positioning modes of 24-hour esophageal pH monitoring: by esophageal manometry and by the pH step-up technique]. Arq Gastroenterol (2009) 1.39

SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet (2010) 1.38

Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns Colitis (2008) 1.36

A method to objectively assess swallow function in adults with suspected aspiration. Gastroenterology (2011) 1.35

Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood (2005) 1.35

Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33

Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut (2011) 1.32

Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut (2009) 1.31

Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol (2003) 1.31

Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. Am J Gastroenterol (2007) 1.30

IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc Natl Acad Sci U S A (2008) 1.30

Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 1.29

Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med (2007) 1.28

Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas. Ann Surg (2006) 1.28

Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res (2004) 1.26

High-resolution Manometry: Esophageal Disorders Not Addressed by the "Chicago Classification". J Neurogastroenterol Motil (2012) 1.26

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26

GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res (2005) 1.24

Nutrient sensing in the gut: new roads to therapeutics? Trends Endocrinol Metab (2012) 1.22

Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood (2003) 1.21

Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm Bowel Dis (2007) 1.21

Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol (2010) 1.21

Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol (2011) 1.20

A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut (2013) 1.20

Dyspepsia: organic versus functional. J Clin Gastroenterol (2012) 1.20

Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) 1.20

Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis (2004) 1.18

The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta (2011) 1.18

Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology (2003) 1.17

Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione. FASEB J (2009) 1.17

A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol (2011) 1.17